Cannabis Bioscience International Holdings, Inc. (CBIH) Accounts Payables (2023 - 2026)
Cannabis Bioscience International Holdings (CBIH) posted Accounts Payables of $190467.0 for Q1 2026, up 19.7% sequentially from $159116.0 in Q4 2025, and up 23.31% YoY from $154466.0 in Q1 2025.
Cannabis Bioscience International Holdings, Inc. (CBIH) Accounts Payables (2023 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has reported Accounts Payables for 4 years, with the latest figure at $190467.0 in Q1 2026.
- Quarterly Accounts Payables rose 23.31% year-over-year to $190467.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $190467.0 (up 23.31% YoY) and the FY2025 annual result came in at $100343.0, down 39.5% from the prior year.
- Accounts Payables rose to $190467.0 in Q1 2026 per CBIH's latest filing, from $159116.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $257527.0 in Q1 2024 and troughed at $100343.0 in Q2 2025.
- A 4-year average of $159665.0 and a median of $159116.0 in 2025 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables surged 49.02% in 2024, then tumbled 40.02% in 2025.
- Over 4 years, Accounts Payables stood at $213521.0 in 2023, then retreated by 22.2% to $166119.0 in 2024, then dropped by 4.22% to $159116.0 in 2025, then advanced by 19.7% to $190467.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $190467.0, $159116.0, and $101297.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 190,467.00 |
| Nov 30, 2025 | 159,116.00 |
| Aug 31, 2025 | 101,297.00 |
| May 31, 2025 | 100,343.00 |
| Feb 28, 2025 | 154,466.00 |
| Nov 30, 2024 | 166,119.00 |
| Aug 31, 2024 | 136,302.00 |
| May 31, 2024 | 165,858.00 |
| Feb 29, 2024 | 257,527.00 |
| Nov 30, 2023 | 213,521.00 |
| May 31, 2023 | 111,299.00 |